Indefinite Delivery Contract SPE2DB25D7055

Award Date 1/29/25
Last Date to Order 11/30/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp is a single-award Indefinite Delivery Contract (IDC) valued at $999,999,999 with a period of performance through November 2026. The contract serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses a broad spectrum of critical medical commodities including...
The federal contract IDV awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical is a single-award Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through November 2026. This contract enables DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies from Amerisourcebergen to support military treatment programs and facilities worldwide. Amerisourcebergen, a major pharmaceutical distributor, leverages its...
The Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. is a single-award contract valued at $999,999,999 through November 2026. This contract serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses a broad spectrum of critical medical commodities, including...
The Defense Logistics Agency (DLA) has awarded an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 to Amerisourcebergen Drug Corp for the delivery of a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract has an ultimate completion date of November 30, 2026. As a major pharmaceutical distributor, Amerisourcebergen will leverage its extensive supply chain network to provide a wide array of...
The federal contract IDV awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division is a single-award Indefinite Delivery Contract (IDC) valued at up to $999,999,999. The contract, which has a period of performance through November 30, 2026, is for the supply of a broad range of pharmaceutical products and medical supplies to support military treatment facilities and other federal healthcare programs nationwide. AmerisourceBergen, as one of the...
The Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. Under this contract, Amerisourcebergen provides...
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical valued at $999,999,999. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic...
The federal contract IDV award is an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials,...
Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has been awarded a single-award Indefinite Delivery Contract (IDC) by the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The contract includes numerous delivery orders...
The provided information describes an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The IDC, valued at $999,999,999 and running through December 2026, serves as a primary vehicle for AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses a...

The federal contract IDV awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp is a $999,999,999 Indefinite Delivery Contract (IDC) for the procurement of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract, which runs through November 2026, covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

This IDC serves as a primary vehicle for the DLA to efficiently acquire essential pharmaceutical and medical supplies to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries. In addition to the DLA contract, Amerisourcebergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, which covers similar medical products and prescription drugs. These contract vehicles enable the government to streamline the procurement of vital pharmaceutical and medical supplies through a comprehensive contracting mechanism with a qualified prime contractor.

Generated 4/30/25, 9:57 AM